Try our mobile app

General information


Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

CV Sciences, Inc. provides specialty pharmaceutical products. The Company focuses on manufacturing, marketing, and selling plant-based CBD products to a range of market sectors, as well as develops CBD-based novel therapeutics utilizing CBD. CV Sciences invests in the scientific evidence necessary to receive self affirmed generally recognized as safe (GRAS) status.
  • Current market environment: negative. Prices of production are 0.9% lower compared to the last 12 months (LTM)
  • Prices of production are at 14.5% percentile over the past 5 years, adjusted for inflation
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 17.9% (LTM), projected 11.3%
  • Share price is 26.0% higher than minimum and 92.1% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (4.6x vs
  • The company is overvalued by EV / projected EBITDA multiple compared to target level (

Key Financials (Download financials)

Ticker: CVSI
Share price, USD:  (-0.8%)0.03654
year average price 0.0396  

year start price 0.0435 2023-04-21

max close price 0.0540 2023-07-12

min close price 0.0290 2023-11-16

current price 0.0368 2024-04-19
Common stocks: 152 599 000

Dividend Yield:  0.0%
FCF Yield LTM / expected: 17.9% / 11.3%
Production prices change from LTM: -0.9%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 6
Net Debt ($m): -1
EV (Enterprise Value): 5
EBITDA LTM ($m): 1
Price to Book: 2.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics


2023-11-14Seeking Alpha

CV Sciences, Inc. (CVSI) Q3 2023 Earnings Call Transcript

2023-08-14Seeking Alpha

CV Sciences, Inc. (CVSI) Q2 2023 Earnings Call Transcript

2023-05-15Seeking Alpha

CV Sciences, Inc. (CVSI) Q1 2023 Earnings Call Transcript
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company